Latest Insider Transactions at National Healthcare Corp (NHC)
This section provides a real-time view of insider transactions for National Healthcare Corp (NHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NATIONAL HEALTHCARE CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NATIONAL HEALTHCARE CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 05
2022
|
Emil E Hassan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+8.71%
|
$540,000
$72.94 P/Share
|
|
May 05
2022
|
Richard F Laroche Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.64%
|
$315,000
$63.27 P/Share
|
|
Feb 25
2022
|
Josh A Mc Creary Senior VP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
1,908
+40.07%
|
-
|
|
Feb 25
2022
|
Robert Michael Ussery President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
4,502
+2.89%
|
-
|
|
Feb 25
2022
|
Vicki L Dodson Sr.VP Patient Srvcs |
BUY
Grant, award, or other acquisition
|
Direct |
1,282
+29.2%
|
-
|
|
Feb 25
2022
|
Jeffrey Russell Smith SVP & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
2,122
+21.05%
|
-
|
|
Feb 25
2022
|
Ben Anderson Sr Flatt Senior VP & CIO |
BUY
Grant, award, or other acquisition
|
Direct |
2,122
+21.48%
|
-
|
|
Feb 25
2022
|
Brian F Kidd SVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
1,940
+8.96%
|
-
|
|
Feb 25
2022
|
Stephen Fowler Flatt CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,800
+7.85%
|
-
|
|
Feb 25
2022
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
1,595
+15.64%
|
-
|
|
Jan 01
2022
|
Vicki L Dodson Sr.VP Patient Srvcs |
SELL
Payment of exercise price or tax liability
|
Direct |
67
-3.72%
|
$4,489
$67.94 P/Share
|
|
Jan 01
2022
|
Robert Michael Ussery President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
544
-0.37%
|
$36,448
$67.94 P/Share
|
|
Jan 01
2022
|
Brian F Kidd SVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
202
-1.13%
|
$13,534
$67.94 P/Share
|
|
Jan 01
2022
|
Stephen Fowler Flatt CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
577
-1.11%
|
$38,659
$67.94 P/Share
|
|
Jan 01
2022
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
173
-2.41%
|
$11,591
$67.94 P/Share
|
|
Jan 01
2022
|
Josh A Mc Creary Senior VP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
108
-10.25%
|
$7,236
$67.94 P/Share
|
|
Jan 01
2022
|
Jeffrey Russell Smith SVP & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
247
-4.06%
|
$16,549
$67.94 P/Share
|
|
Jan 01
2022
|
Ben Anderson Sr Flatt Senior VP & CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
247
-4.51%
|
$16,549
$67.94 P/Share
|
|
Dec 30
2021
|
Richard F Laroche Jr Director |
SELL
Bona fide gift
|
Direct |
5,000
-2.57%
|
-
|
|
Dec 29
2021
|
Richard F Laroche Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.51%
|
$305,000
$61.9 P/Share
|
|
Nov 05
2021
|
Vicki L Dodson Sr.VP Patient Srvcs |
SELL
Payment of exercise price or tax liability
|
Direct |
5,811
-76.36%
|
$441,636
$76.35 P/Share
|
|
Nov 05
2021
|
Vicki L Dodson Sr.VP Patient Srvcs |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+44.09%
|
$432,000
$72.94 P/Share
|
|
Nov 05
2021
|
Brian F Kidd SVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
33,445
-65.11%
|
$2,541,820
$76.35 P/Share
|
|
Nov 05
2021
|
Brian F Kidd SVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
34,630
+40.27%
|
$2,493,360
$72.94 P/Share
|
|
Nov 05
2021
|
Stephen Fowler Flatt CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
38,633
-42.58%
|
$2,936,108
$76.35 P/Share
|
|
Nov 05
2021
|
Stephen Fowler Flatt CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+30.6%
|
$2,880,000
$72.94 P/Share
|
|
Nov 04
2021
|
Ben Anderson Sr Flatt Senior VP & CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,174
-80.89%
|
$1,761,224
$76.35 P/Share
|
|
Nov 04
2021
|
Ben Anderson Sr Flatt Senior VP & CIO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,000
+45.59%
|
$1,728,000
$72.94 P/Share
|
|
Aug 31
2021
|
Brian F Kidd SVP, CFO |
SELL
Bona fide gift
|
Direct |
400
-2.33%
|
-
|
|
May 27
2021
|
W Andrew Adams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+16.49%
|
$465,000
$62.78 P/Share
|
|
May 19
2021
|
Emil E Hassan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+9.54%
|
$465,000
$62.78 P/Share
|
|
Apr 27
2021
|
Ernest G Burgess Iii Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+3.17%
|
$186,000
$62.78 P/Share
|
|
Apr 27
2021
|
Richard F Laroche Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+3.81%
|
$465,000
$62.78 P/Share
|
|
Mar 19
2021
|
Ernest G Burgess Iii Director |
SELL
Bona fide gift
|
Direct |
1,300
-0.73%
|
-
|
|
Mar 18
2021
|
Jeffrey Russell Smith SVP & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
43,811
-87.8%
|
$3,461,069
$79.21 P/Share
|
|
Mar 18
2021
|
Jeffrey Russell Smith SVP & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
46,630
+48.31%
|
$3,357,360
$72.74 P/Share
|
|
Mar 15
2021
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
13,109
-64.62%
|
$1,022,502
$78.99 P/Share
|
|
Mar 15
2021
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+44.1%
|
$960,000
$60.73 P/Share
|
|
Mar 15
2021
|
Emil E Hassan Director |
SELL
Open market or private sale
|
Direct |
1,913
-2.92%
|
$151,127
$79.0 P/Share
|
|
Mar 02
2021
|
James Paul Abernathy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,020
+6.91%
|
$123,220
$61.9 P/Share
|
|
Mar 02
2021
|
Robert G Adams Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,750
+0.64%
|
$198,000
$72.94 P/Share
|
|
Feb 24
2021
|
Vicki L Dodson Sr.VP Patient Srvcs |
BUY
Grant, award, or other acquisition
|
Direct |
421
+20.73%
|
-
|
|
Feb 24
2021
|
Josh A Mc Creary Senior VP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
633
+37.52%
|
-
|
|
Feb 24
2021
|
Brian F Kidd SVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
626
+3.52%
|
-
|
|
Feb 24
2021
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
510
+10.64%
|
-
|
|
Feb 24
2021
|
Stephen Fowler Flatt CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,650
+3.15%
|
-
|
|
Feb 24
2021
|
Jeffrey Russell Smith SVP & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
739
+18.45%
|
-
|
|
Feb 24
2021
|
Ben Anderson Sr Flatt Senior VP & CIO |
BUY
Grant, award, or other acquisition
|
Direct |
742
+13.77%
|
-
|
|
Feb 24
2021
|
Robert Michael Ussery President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
1,565
+1.05%
|
-
|
|
Jan 06
2021
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
6,905
-64.65%
|
$504,065
$73.97 P/Share
|